ADDISON VOTH: Open Payments
NPI 1013378215 · NEWTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 28 payments from 9 companies in 2025. Trend: 2023 $1,065 · 2024 $1,152 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $102 |
| ABBVIE INC. | 5 | $101 |
| Astellas Pharma US Inc | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $16 |
Products named: VRAYLAR, NURTEC ODT, Veozah, Kerendia, GEMTESA, PREVNAR 20, EVENITY, BREZTRI.
Industry payments across KS — which companies pay providers there.
